The aim of this study was to assess the efficacy and tolerability of olaparib in combination with chemotherapy, followed by olaparib maintenance monotherapy, versus chemotherapy alone in patients with platinum–sensitive, recurrent, high–grade serous ovarian cancer.

READ FULL ARTICLE Curated publisher From Mdlinx